News

World's first primary standard developed for molecular radiotherapy

The new primary standard for MRT
The new primary standard for MRT

Researchers from EMRP project develop the world's first primary standard for molecular radiotherapy (MRT) to treat cancer

The new standard will help improve the consistency of MRT treatments, in which radioactive molecules, or radiopharmaceuticals, are injected directly into a patient's body to target and kill cancerous cells. Such standardisation is vital to encourage more widespread use of MRT and develop new and improved radiopharmaceuticals.

Like any form of radiotherapy, the success of MRT relies on the delivery of an extremely precise dose of radiation. The goal is to maximise the dose delivered to the tumour, while minimising damage to surrounding healthy tissue. However, in contrast to other forms of radiotherapy, dosimetry for MRT is not well established. Researchers from EMRP project Metrology for molecular radiotherapy (HLT11 MetroMRT) developed the new standard.  A gas-filled ionisation chamber, containing two parallel electrodes an adjustable distance apart, enables the user to measure the absorbed radiation dose from a radioactive solution.

Select your area of interest
First standard for dynamic measurement of liquefied hydrocarbons is published
2020-09-01

EMPIR projects improve flow measurements for liquefied natural gas & other refrigerated hydrocarbon fluids to support the EU’s energy transition more

EMN Energy Gases welcomes Justervesenet as its 17th member
2020-08-17

The European Metrology Network for Energy Gases welcomes its newest member, Justervesenet, the Norwegian Metrology Institute more

Survey for the biofuel industry
2020-08-05

New EMPIR project launches stakeholder survey to help assess industry needs more

The NIBSC, a member of TraceLabMed, supports vital COVID-19 research
2020-08-04

Developing reference materials and standards to fight against the spread of the coronavirus more

Page 1 of 160.